Avadel Pharmaceuticals (AVDL) EPS (Basic) (2016 - 2021)
Historic EPS (Basic) for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q4 2020 value amounting to -$0.04.
- Avadel Pharmaceuticals' EPS (Basic) rose 9639.38% to -$0.04 in Q4 2020 from the same period last year, while for Dec 2020 it was $0.12, marking a year-over-year increase of 10600.51%. This contributed to the annual value of -$0.12 for FY2020, which is 9413.32% up from last year.
- Per Avadel Pharmaceuticals' latest filing, its EPS (Basic) stood at -$0.04 for Q4 2020, which was up 9639.38% from -$0.2 recorded in Q3 2020.
- Avadel Pharmaceuticals' EPS (Basic)'s 5-year high stood at $0.7 during Q2 2017, with a 5-year trough of -$1.71 in Q4 2018.
- For the 5-year period, Avadel Pharmaceuticals' EPS (Basic) averaged around -$0.19, with its median value being -$0.2 (2017).
- In the last 5 years, Avadel Pharmaceuticals' EPS (Basic) soared by 52000.0% in 2017 and then plummeted by 73923.77% in 2018.
- Quarter analysis of 5 years shows Avadel Pharmaceuticals' EPS (Basic) stood at $0.11 in 2016, then tumbled by 277.54% to -$0.2 in 2017, then plummeted by 739.24% to -$1.71 in 2018, then grew by 28.8% to -$1.22 in 2019, then skyrocketed by 96.39% to -$0.04 in 2020.
- Its last three reported values are -$0.04 in Q4 2020, -$0.2 for Q3 2020, and $0.57 during Q2 2020.